Ketamine/sufentanil nasal spray (Cessatech)

氯胺酮/舒芬太尼鼻喷雾剂(Cessatech)

Report date: 2025/05/20 15:30:57

Base Information

Drug NameKetamine/sufentanil nasal spray (Cessatech)
Drug Alias NameCT-001CT-001 (Cessatech)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonistsMu opioid receptor agonists
TargetsGlutamate [NMDA] receptorMu opioid receptor
Therapy Area/IndicationsPainHemorrhageAnesthesia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmarkUnited KingdomSpain
CombinationsYes Ketamine
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesCessatech A/S
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPainHemorrhageAnesthesia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A